FDA: HOLOGIC RECALL DUE TO REPORTS OF SERIOUS ADVERSE EVENTS OCCURRING IN PATIENTS WHO HAD BIOZORB MARKER DEVICES IMPLANTED IN BREAST TISSUE

Reuters · 10/25 17:07

Please log in to view news